Others

Norris Medicines Ltd. - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

| Updated on March 27, 2019 Published on March 27, 2019

With reference to above subject, we would like to inform you that Board of Directors at its meeting held on today, i.e, 27th March, 2019, approved the amendment in "Code of Conduct for Prevention of Insider Trading and Fair Disclosure of Unpublished Price Sensitive Information" in view of SEBI (Prohibition of Insider Trading) (Amendment) Regulation, 2018 and subsequent amendment to SEBI (PIT) Regulation notified on January 21, 2019 which, inter alia, defines policy to determine "Legitimate Purpose". The said revised Code of Conduct will be applicable with effect from April 1, 2019 and existing code of the Company is being applicable upto March 31, 2019.

We are submitting herewith the revised "Code of Conduct for Prevention .of Insider Trading and Fair Disclosure of Unpublished Price Sensitive Information" for records and disseminate to the stakeholders. The said revised code is being made available on Companys website under the Company Policies.

Pdf Link: Norris Medicines Ltd. - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

Source : BSE - www.bseindia.com

Published on March 27, 2019
This article is closed for comments.
Please Email the Editor